Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer

Cancer Research

Volumn 62, Issue 22, 2002, Pages 6430-6433

  Yu, Chunyuan ^a   Pan, Kaifeng ^b   Xing, Deyin ^a   Liang, Gang ^a   Tan, Wen ^a   Zhang, Lian ^b   Lin, Dongxin ^a  

^a CANCER HOSPITAL   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; GELATINASE A;

ADULT; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE ACTIVITY; GENE DISRUPTION; GENE FREQUENCY; GENE SEQUENCE; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT;

CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RISK FACTORS; SEX FACTORS; SMOKING;

EID: 0037112445     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Hart, I. R., and Saini, A. Biology of tumor metastasis. Lancet, 339: 1453-1457, 1992
2. Kohn, E. C., and Liotta. L. A. Molecular insight into cancer invasion: Strategies for prevention and intervention. Cancer Res., 55: 1856-1862, 1995
3. Werb, Z. ECM and cell surface proteolysis: Regulating cellular ecology. Cell. 91: 439-442, 1991
4. Stamenkovic, I. Matrix metalloproteinases in tumor invasion and metastasis. Semin. Cancer Biol., 10: 415-433, 2000
5. McCawley, L. J., and Matrisian, L. M. Matrix metalloproteinases: Multifunctional contributors to tumor progression. Mol. Med. Today. 6: 149-156. 2000
6. Zhu, Y., Spitz. M. R., Lei, L., Mills, G. B., and Wu, X. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res., 61: 7825-7829, 2001
7. Galateau-Salle, F. B., Luna, R. E., Horiba, K., Sheppard, M. N., Hayashi, T., Fleming, M. V., Colby, T. V., Bennett, W., Harris, C. C., Stetler-Stevenson, W. G., Liotta, L., Ferrans, V. J., and Travis, W. D. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions. Hum. Pathol., 31: 296-305, 2000
8. Egeblad, M., and Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer. 2: 161-174, 2002
9. Nagase, H., and Woessner, J. F., Jr. Matrix metalloproteinase. J. Biol. Chem., 274: 21491-21492, 1999
10. Boag, A. H., and Young, I. D. Increased expression of the 72 kDa type IV collagenase in prostatic adenocarcinoma. Am. J. Pathol., 144: 585-591, 1994
11. Schmalfeldt, B., Prechtel, D., Harting, K., Spathe, K., Rutke, S. S., Konik, E., Fridman, R., Berger, U., Schmitt, M., Kuhn, W., and Lengyel, E. Increased expression of matrix metalloproteinases (MMP)-2. MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin. Cancer Res., 7: 2396-2404, 2001
12. Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., and Itohara, S. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res., 58: 1048-1051, 1998
13. Hrabec, E., Strek, M., Nowak, D., Greger, J., Suwalski, M., and Hrabec, Z. Activity of type IV collagenases (MMP-2 and MMP-9) in primary pulmonary carcinomas: A quantitative analysis. J. Cancer Res. Clin. Oncol., 128: 197-204, 2002
14. Price, S. J., Greaves, D. R., and Watkins, H. Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: Role of Spl in allele-specific transcriptional regulation. J. Biol. Chem., 276: 7549-7558, 2001
15. Xing, D., Tan, W., Wei, Q., and Lin, D. Polymorphisms of the DNA repair gene XPD and risk of lung cancer in a Chinese population. Lung Cancer, 38: 123-129, 2002
16. Gross, E., Arnold, N., Goette, J., Schwarz-Boeger, U., and Kiechle, M. A comparison of BRCA1 mutation analysis by direct sequencing: SSCP and DHPLC. Hum. Genet., 105: 72-78, 1999
17. Bian, J., and Sun, Y. Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol. Cell. Biol., 17: 6330-6338, 1997
18. Kleinbaum, D. G., Kupper, L. L., and Morgenstem, H. Epidemiologic Research: Principles and Quantitative Methods. London, United Kingdom: Lifetime Learning Publications, 1982
19. Qin, H., Sun, Y., and Benveniste, E. N. The transcription factors Sp1. Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J. Biol. Chem., 274: 29130-29137, 1999
20. Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., and Hanahan, D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol., 2: 737-744, 2000
21. Coussens, L. M., Tinkle, C. L., Hanahan, D., and Werb, Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell, 103: 481-490, 2000
22. Masson, R., Lefebvre, O., Noel. A., Fahime, M. E., Chenard, M. P., Wendling, C., Kebers, F., LeMeur, M., Dierich, A., Foidart, J. M., Basset, P., and Rio, M. C. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J. Cell Biol., 140: 1535-1541, 1998
23. Stemlicht, M. D., Lochter, A., Sympson, C. J., Huey, B., Rougier, J. P., Gray, J. W., Pinkel, D., Bissell, M. J., and Werb, Z. The stromal proteinase MMP-3/stromelysin-1 promotes mammary carcinogenesis. Cell, 98: 137-146. 1999
24. Ha, H. Y., Moon, H. B., Nam, M. S., Lee, J. W., Ryoo, Z. Y., Lee, T. H., Lee. K. K., So, B. J., Sato, H., Seiki, M., and Yu, D. Y. Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice. Cancer Res., 61: 984-990, 2001
25. Manes, S., Llorente, M., Lacalle, R. A., Gomez-Mouton, C., Kremer, L., Mira, E., and Martinez-A, C. The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells. J. Biol. Chem., 274: 6935-6945, 1999
26. Yu, H., and Rohan, T. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst., 92: 1472-1478, 2000
27. Peschon, J. J., Slack, J. L. Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N., Boyce, R. W., Nelson, N., Kozlosky, C. J., Wolfson, M. F., Rauch, C. T., Cerretti, D. P., Paxton, R. J., March, C. J., and Black, R. A. An essential role for ectodomain shedding in mammalian development. Science (Washington DC), 282, 1281-1284, 1998
28. Tlsty, T. D. Cell-adhesion-dependent influences on genomic instability and carcinogenesis. Curr. Opin. Cell Biol., 10: 647-653, 1998
29. Lahman, C., Bergemann, J., Harrison, G., and Young, A. R. Matrix metalloproteinase-1 and skin ageing in smokers. Lancet, 357: 935-936, 2001
30. Russell, R. E., Culpitt, S. V., DeMatos, C., Donnelly, L., Smith, M., Wiggins, J., and Barnes, P. J. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol., 26: 602-609, 2002